Hair Loss Cures 2025
Atticus Pharma, a clinical-stage biopharmaceutical company specializing in immunodermatology treatments, has announced the initiation of its first human clinical trial of ATC-002 for androgenic alopecia. What is Atticus Pharma? Atticus Pharma was founded in 2024 to develop pharmaceutical applications of its proprietary Z-pod® technology, a sustained-release drug delivery platform designed to improve treatment outcomes in…
Read More
After a slow and disappointing winter season in 2024, we start the year with some positive news in the androgenic alopecia space. Eirion Therapeutics, a clinical-stage biopharmaceutical company with oral and topical androgenic alopecia treatments in the pipeline, has announced results from their 4-week androgenic alopecia trial of topical ET-02. What Is ET-02? We don’t…
Read More